Aqua Bio Technology ASA (ABT.OL)
NOK 6.93
(0.0%)
NOK 6.93
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.96 Million | -13.33 Million | -17.19 Million | -17.31 Million | -16.36 Million | 25.79 Million |
| Net Income | -19.11 Million | -14.95 Million | -13.21 Million | -18.36 Million | -14.81 Million | 2.23 Million |
| Depreciation & Amortization | 1.09 Million | 112.79 Thousand | 272.91 Thousand | 855.94 Thousand | 937.19 Thousand | 4.21 Million |
| Deferred income taxes | - | 2741.00 | - | - | 26.95 Thousand | 13.41 Million |
| Stock-based compensation | 1.79 Million | 546.03 Thousand | - | - | 6760.00 | 822.45 Thousand |
| Change in working capital | -4.74 Million | 959.1 Thousand | -4.16 Million | 244.25 Thousand | -2.42 Million | 5.16 Million |
| Other non-cash items | 670.00 | -2735.00 | -82.29 Thousand | -52.92 Thousand | -93.24 Thousand | -61.69 Thousand |
| Investing Cash Flow | -5.4 Million | -3.26 Million | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Investments in PPE | -3.86 Million | -135.68 Thousand | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Acquisitions | -1.53 Million | -3.13 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 34.3 Million | 15.15 Million | 20.7 Million | -897.51 Thousand | -7.05 Million | -20.49 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | -6.22 Million | -16.92 Million |
| Common Stock Repurchased | -1.1 Million | - | - | - | - | - |
| Common Stock Issuance | 27.7 Million | 15.15 Million | 21.06 Million | - | - | 300 Thousand |
| Other Financing Activities | 7.69 Million | -6.00 | -354.18 Thousand | -897.51 Thousand | -833.41 Thousand | -3.86 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.88 Million | - | - | 815.89 Thousand | -2.03 Million | 1.3 Million |
| Other working capital | 138.97 Thousand | - | - | -571.63 Thousand | -390.54 Thousand | 3.85 Million |
| Cash at beginning of period | 5.42 Million | 6.87 Million | 3.27 Million | 21.81 Million | 46.19 Million | 41.99 Million |
| Cash at end of period | 13.35 Million | 5.42 Million | 6.87 Million | 3.27 Million | 21.81 Million | 46.19 Million |
| Capital Expenditure | -3.86 Million | -135.68 Thousand | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Effect of forex changes on cash | - | - | 111.47 Thousand | 23.77 Thousand | -26.95 Thousand | -689.46 Thousand |
| Net cash flow / Change in cash | 7.92 Million | -1.44 Million | 3.6 Million | -18.54 Million | -24.38 Million | 4.2 Million |
| Free Cash Flow | -24.83 Million | -13.47 Million | -17.21 Million | -17.67 Million | -17.29 Million | 25.38 Million |
| Breakdown | 2021 FY | 2020 FY | 2019 FY | 2018 FY | 2017 FY | 2016 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -19.11 Million | -14.95 Million | -13.21 Million | -18.36 Million | -14.81 Million | 2.23 Million |
| Depreciation & Amortization | 1.09 Million | 112.79 Thousand | 272.91 Thousand | 855.94 Thousand | 937.19 Thousand | 4.21 Million |
| Deferred income taxes | - | 2741.00 | - | - | 26.95 Thousand | 13.41 Million |
| Stock-based compensation | 1.79 Million | 546.03 Thousand | - | - | 6760.00 | 822.45 Thousand |
| Change in working capital | -4.74 Million | 959.1 Thousand | -4.16 Million | 244.25 Thousand | -2.42 Million | 5.16 Million |
| Other non-cash items | 670.00 | -2735.00 | -82.29 Thousand | -52.92 Thousand | -93.24 Thousand | -61.69 Thousand |
| Investing Cash Flow | -5.4 Million | -3.26 Million | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Investments in PPE | -3.86 Million | -135.68 Thousand | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Acquisitions | -1.53 Million | -3.13 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 34.3 Million | 15.15 Million | 20.7 Million | -897.51 Thousand | -7.05 Million | -20.49 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | -6.22 Million | -16.92 Million |
| Common Stock Repurchased | -1.1 Million | - | - | - | - | - |
| Common Stock Issuance | 27.7 Million | 15.15 Million | 21.06 Million | - | - | 300 Thousand |
| Other Financing Activities | 7.69 Million | -6.00 | -354.18 Thousand | -897.51 Thousand | -833.41 Thousand | -3.86 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.88 Million | - | - | 815.89 Thousand | -2.03 Million | 1.3 Million |
| Other working capital | 138.97 Thousand | - | - | -571.63 Thousand | -390.54 Thousand | 3.85 Million |
| Cash at beginning of period | 5.42 Million | 6.87 Million | 3.27 Million | 21.81 Million | 46.19 Million | 41.99 Million |
| Cash at end of period | 13.35 Million | 5.42 Million | 6.87 Million | 3.27 Million | 21.81 Million | 46.19 Million |
| Capital Expenditure | -3.86 Million | -135.68 Thousand | -17.83 Thousand | -358.43 Thousand | -935.5 Thousand | -408.25 Thousand |
| Effect of forex changes on cash | - | - | 111.47 Thousand | 23.77 Thousand | -26.95 Thousand | -689.46 Thousand |
| Net cash flow / Change in cash | 7.92 Million | -1.44 Million | 3.6 Million | -18.54 Million | -24.38 Million | 4.2 Million |
| Free Cash Flow | -24.83 Million | -13.47 Million | -17.21 Million | -17.67 Million | -17.29 Million | 25.38 Million |
000410
NMR
LISP
GMXDF
GPAK
HGPI